Abstract

<h3>Objective:</h3> To report on parental leave policies in U.S. adult neurology residencies and explore barriers to augmenting the duration of paid leave. <h3>Background:</h3> Though the American Board of Psychiatry and Neurology (ABPN) requires that programs allow at least 6 weeks of parental leave, there is little information about the status of parental leave policies across U.S. neurology residencies. <h3>Design/Methods:</h3> We distributed an anonymous online survey to U.S. adult neurology program directors (PDs). The survey addressed program demographics, components and length of parental leave, perceived impact on residents’ clinical training and academic development, and barriers to augmenting the policy. <h3>Results:</h3> We contacted 163 PDs and received 54 responses (response rate of 33%). 87% of programs had policies for both childbearing and non-childbearing residents. The average maximal length of leave without extension of training was 8.5 weeks (range 0–13) for childbearing residents and 6.2 weeks (0–13) for non-childbearing residents. 65% offered full pay and benefits during the leave, and a majority did not require full use of vacation (51%) or elective time (59%). 42% had policies for reducing clinical rotations to create a leave. The majority of PDs felt that parental leave had a positive impact on resident wellness and neutral impact on clinical competency, academic opportunities, and career development. PDs stated that the most common barriers to providing a 12-week paid policy were concerns about equity in the program and impact on other trainees (82%), staffing of clinical services (80%), and impact on clinical training (78%). <h3>Conclusions:</h3> Although most adult U.S. neurology programs in our cross-sectional study have established parental leave policies, there is significant variability regarding the duration of leave and the composition of leave that is offered. Policies to improve parental leave should focus on addressing commonly perceived barriers, such as additional solutions to staffing clinical services. <b>Disclosure:</b> Dr. Conway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Prasad has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicolegal firms. Dr. Prasad has stock in health care companies. Dr. Prasad has received publishing royalties from a publication relating to health care.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call